Antioxidant status in women with uterine leiomyoma: relation with sex hormones.

Uterine leiomyomas are benign soft-tissues tumors that arise from uterine smooth muscle tissue. Etiopathogenesis of leiomyomas is not well understood. We aimed to examine whether antioxidant enzyme activities and lipid hydroperoxides level in patients with leiomyoma are influenced by changes in sex hormones and gonadotropins (estradiol (E2), progesterone, FSH, and LH) during menstrual cycle and in postmenopause. The material consisted of blood and uterine tissue specimens. Hormone concentrations were determined and assays for superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase activities and lipid hydroperoxides concentration were performed. In blood of examined women, a significant difference in catalase, glutathione peroxidase and glutathione reductase activity was recorded among the phases. There was also a positive correlation between the estradiol/progesterone concentration and the catalase activity. Progesterone negatively correlated with lipid hydroperoxides level. In myoma tissue, we recorded a phase-related difference in lipid hydroperoxides level and activities of superoxide dismutase, glutathione peroxidase activities, and glutathione reductase. Negative correlation was observed between FSH and glutathione peroxidase. The results suggest that antioxidant status in patients with uterine leiomyoma is influenced by the changes in sex hormones during the menstrual cycle and in postmenopause, indicating a role of the observed relationship in the leiomyoma etiology.

[1]  S. Badawy.  Leiomyoma of the Uterus , 2017 .

[2]  Yinghua Yang,et al.  Effect of bone morphogenetic protein-4 on in vitro growth, steroidogenesis and subsequent developmental competence of the oocyte-granulosa cell complex derived from bovine early antral follicles , 2016, Reproductive Biology and Endocrinology.

[3]  H. Sies.  Role of Metabolic H2O2 Generation , 2014, The Journal of Biological Chemistry.

[4]  Md Soriful Islam,et al.  Uterine Fibroids: Pathogenesis and Interactions with Endometrium and Endomyometrial Junction , 2013, Obstetrics and gynecology international.

[5]  L. Juliano,et al.  17β-Estradiol and steady-state concentrations of H2O2: antiapoptotic effect in endometrial cells from patients with endometriosis. , 2013, Free radical biology & medicine.

[6]  A. Agarwal,et al.  The role of oxidative stress in menopause , 2013, Journal of mid-life health.

[7]  A. M. Pinto-Neto,et al.  Tratamento pós-menopausa reduz a atividade da catalase e atenua o risco cardiovascular , 2012 .

[8]  A. Alfadda,et al.  Reactive Oxygen Species in Health and Disease , 2012, Journal of biomedicine & biotechnology.

[9]  P. Naik,et al.  Effect of Free Radicals & Antioxidants on Oxidative Stress: A Review , 2012 .

[10]  A. Pinto-Neto,et al.  Postmenopausal therapy reduces catalase activity and attenuates cardiovascular risk. , 2012, Arquivos brasileiros de cardiologia.

[11]  Rafael Radi,et al.  Factors affecting protein thiol reactivity and specificity in peroxide reduction. , 2011, Chemical research in toxicology.

[12]  D. Dixon,et al.  Receptor tyrosine kinases and their hormonal regulation in uterine leiomyoma. , 2010, Seminars in reproductive medicine.

[13]  B. Dahlbäck,et al.  Plasma concentrations of apolipoproteins A-I, B and M in patients with abdominal aortic aneurysms. , 2010, Clinical biochemistry.

[14]  J. Kasapović,et al.  Antioxidant enzymes and lipid peroxidation in endometrium of patients with polyps, myoma, hyperplasia and adenocarcinoma , 2009, Reproductive biology and endocrinology : RB&E.

[15]  Jun Liu,et al.  Hydrogen Peroxide Induces G2 Cell Cycle Arrest and Inhibits Cell Proliferation in Osteoblasts , 2009, Anatomical record.

[16]  C. Nicco,et al.  Reactive oxygen species controls endometriosis progression. , 2009, The American journal of pathology.

[17]  R. Neuwirth,et al.  Leiomyomas of the Uterus , 2009 .

[18]  S. Pejić,et al.  Superoxide dismutase and lipid hydroperoxides in blood and endometrial tissue of patients with benign, hyperplastic and malignant endometrium. , 2008, Anais da Academia Brasileira de Ciencias.

[19]  H. Burger,et al.  A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. , 2007, Human reproduction update.

[20]  R. E. Blake,et al.  Leiomyomata uteri: hormonal and molecular determinants of growth. , 2007, Journal of the National Medical Association.

[21]  P. Evans,et al.  Uterine fibroid tumors: diagnosis and treatment. , 2007, American family physician.

[22]  Sajal Gupta,et al.  Role of oxidative stress in female reproduction , 2005, Reproductive biology and endocrinology : RB&E.

[23]  S. Neelima,et al.  Status of antioxidant enzymes and trace metals in postmenopausal women , 2005 .

[24]  A. Bohdanowicz-Pawlak,et al.  Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy , 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[25]  E. Wallach,et al.  Uterine Myomas: An Overview of Development, Clinical Features, and Management , 2004, Obstetrics and gynecology.

[26]  H. Matsuo,et al.  Sex steroidal regulation of uterine leiomyoma growth and apoptosis. , 2004, Human reproduction update.

[27]  D. Kufe,et al.  Catalase is regulated by ubiquitination and proteosomal degradation. Role of the c-Abl and Arg tyrosine kinases. , 2003, Biochemistry.

[28]  D. Dixon,et al.  Etiology and pathogenesis of uterine leiomyomas: a review. , 2003, Environmental health perspectives.

[29]  B. Panczenko-Kresowska,et al.  Plasma TBARS, blood GSH concentrations, and erythrocyte antioxidant enzyme activities in regularly menstruating women with ovulatory and anovulatory menstrual cycles. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[30]  I. Grattagliano,et al.  Modulation of endometrial redox balance during the menstrual cycle: relation with sex hormones. , 2002, The Journal of clinical endocrinology and metabolism.

[31]  H. Matsuo,et al.  Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells. , 2002, European journal of endocrinology.

[32]  K. Kovács,et al.  Comparative analysis of cyclin D1 and oestrogen receptor (α and β) levels in human leiomyoma and adjacent myometrium , 2001 .

[33]  P. Andersen,et al.  [Endovascular treatment of uterine fibromas]. , 2001, Ugeskrift for laeger.

[34]  M. Harma,et al.  Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. , 2001, Clinical biochemistry.

[35]  M. Melone,et al.  17‐B estradiol elicits an autocrine leiomyoma cell proliferation: Evidence for a stimulation of protein kinase‐dependent pathway , 2001 .

[36]  A. Bohdanowicz-Pawlak,et al.  Serum lipid peroxide levels and erythrocyte glutathione peroxidase and superoxide dismutase activity in premenopausal and postmenopausal women , 2001, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[37]  L. Hodges,et al.  Uterine Leiomyomas: Mechanisms of Tumorigenesis , 2001, Toxicologic pathology.

[38]  V. de Leo,et al.  Effects of estrogens and androgens on erythrocyte antioxidant superoxide dismutase, catalase and glutathione peroxidase activities during the menstrual cycle. , 2000, The Journal of endocrinology.

[39]  M. Rein,et al.  Advances in uterine leiomyoma research: the progesterone hypothesis. , 2000, Environmental health perspectives.

[40]  N. Sugino,et al.  Induction of superoxide dismutase by decidualization in human endometrial stromal cells. , 2000, Molecular human reproduction.

[41]  G. Buonocore,et al.  Variations in erythrocyte antioxidant glutathione peroxidase activity during the menstrual cycle , 1998, Clinical endocrinology.

[42]  G. Buonocore,et al.  Effects of estradiol and medroxyprogesterone-acetate treatment on erythrocyte antioxidant enzyme activities and malondialdehyde plasma levels in amenorrhoic women. , 1997, The Journal of clinical endocrinology and metabolism.

[43]  G. Buonocore,et al.  Changes in the erythrocyte antioxidant enzyme system during transdermal estradiol therapy for secondary amenorrhea. , 1996, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[44]  M. Gast.  A new generation of oral contraceptive progestins: Guest Introduction , 1996 .

[45]  C. Romanini,et al.  Transdermal estradiol and medroxyprogesterone acetate in hormone replacement therapy are both antioxidants. , 1995, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[46]  A. Ghidini,et al.  Natural history of uterine leiomyomas in pregnancy. , 1994, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[47]  G. Buonocore,et al.  Antioxidant erythrocyte enzyme activities during oral contraception. , 1993, Contraception.

[48]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[49]  W. Crocker.  Catalase , 1911, Botanical Gazette.